Autor: |
Eirini P. Papapetrou, Dan Hasson, Michael G. Kharas, Hanzhi Luo, Ravindra Majeti, Mark P. Chao, Elsa Bernard, Chan-Jung Chang, Deniz Demircioglu, Tiansu Wang, Malgorzata Olszewska, Nataly Cruz-Rodriguez, Saul Carcamo, Andriana G. Kotini |
Rok vydání: |
2023 |
DOI: |
10.1158/2643-3230.22645264 |
Popis: |
Table S1. Patient characteristics. AML: acute myeloid leukemia; MDS: myelodysplastic syndrome; MPN: myeloproliferative neoplasm; ET: essential thrombocythemia; PBMCs: peripheral blood mononuclear cells; BMMCs: bone marrow mononuclear cells; PDX: patient-derived xenografts Table S2. All patient samples used in this study with genetic characterization and reprogramming outcomes. Blue font denotes partially reprogrammed (as opposed to bona fide iPSC) colonies and clones. Table S3. All AML-iPSC lines phenotypically characterized. Table S4. Top 50 upregulated genes (highest log2 fold change) in each cluster. Table S5. Primers used for genotyping. Table S6. Primers used for qRT-PCR analyses. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|